Nateglinide (Starlix)

Nateglinide is a medication that was first approved as a monotherapy for type 2 diabetes in 2001. It is currently approved for use alone or in combination with metformin, another leading oral anti-diabetic agent.

Nateglinide overview

Brand name: Nateglinide is marketed as Starlix.

Drug class: Starlix belongs to a class of drugs called meglitinides. These drugs work to lower blood sugar levels by stimulating the pancreas to release more insulin. Effectiveness of meglitinides depends on how much glucose, or sugar, is present in the blood. Unlike a number of other diabetes treatments, Starlix causes the pancreas to release insulin only when glucose is present in the body, which can help patients avoid hypoglycemia.

Dosage: The recommended dose, when used alone or in combination with metformin, is 120 mg taken orally three times daily before meals.

Side effects: Possible common side effects of Starlix can include flu-like symptoms, upper respiratory infection, dizziness and joint pain.

Sign up for our newsletter
  • Get diabetes supplies
    delivered to your door.
  • Find companies that offer free
    delivery of the brands you want.

  • Diabetes supplies
     CPAP mask and tubing
  • How would you describe yourself?

  • Do you have Medicare as your primary insurance?
  • Yes No

Related Medications Content

Add a comment
Google Plus
(required) *
(required,will not be displayed) *
Can't read this?
Get two new words
Listen to the words